Videos

Facible Biodiagnostics | Steven Burden, CEO

Facible Biodiagnostics is leading the diagnostic testing revolution through our mission to provide hospital-grade diagnostic tests to everyone, everywhere.

Facible Biodiagnostics | Clémentine Gibard Bohachek, CSO

Facible Biodiagnostics is leading the diagnostic testing revolution through our mission to provide hospital-grade diagnostic tests to everyone, everywhere.

New York Huaqi Bioengineering | Lili Xu, CEO

New York Huaqi Bioengineering is developing products to preserve and enhance the health and functionality of donated human organs.

Aspect BioSystems | Tamer Mohamed, CEO

Combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics.

Acorn BioLabs | Drew Taylor, CEO

Acorn is developing a non-insaive cryopreservation solution for the preservation of healthy follicle cells for use in cellular treatments.

Exciton Pharma | Carla Spina, CSO

Exciton Pharma Corp (EPC) is a late-stage pre-clinical, multi-asset biotech company developing first-in-class compounds for the inclusive treatment of infection and skin diseases.

ChemoTech | Mohan Frick, CEO

The company is dedicated to innovation in cancer care and recently launched IQwave. This technology performs electrochemotherapy which is approved for the treatment of a wide range of tumors.

MagForce USA | Ben Lipps, CEO

Nanotechnology-based therapy for the treatment of cancer.

Rapid Nexus | Dr. Margaret Kalmeta, CEO & Founder

Rapid Nexus has developed a first of its kind nanotechnology wound dressing, along with devices that accelerate healing, to rapidly close chronic non-healing wounds.

Synova Life Sciences | John Chi, CEO

Synova Life Sciences a biotechnology company that has developed a proprietary methodology and system for processing fat cells into autologous stem cells.